Sexual Dysfunction

Impact of vulvovaginal atrophy on sexual function in postmenopausal women

April 09, 2020

New research indicates having at least one symptom of vulvovaginal atrophy is linked to significant impaired sexual function for postmenopausal women.

Perimenopause’s negative impact on sexual function

November 22, 2019

According to research published in Menopause, vaginal atrophy-a treatable condition-appears to be the most impactful factor for perimenopausal women and declining sexual function.

Female cyclists and sexual dysfunction

September 09, 2019

A recent study examined how bicycle seats may play a role in the prevalence of sexual dysfunction among female adult bicyclists.

Association between epilepsy and risk of sexual dysfunction

July 17, 2019

Ob/gyns treating patients with epilepsy should be aware of their higher risk for sexual dysfunction while also recognizing that the cause may be multifactorial. 

Sexual dysfunction treatment approved by FDA

July 02, 2019

Bremelanotide is an injectable indicated for premenopausal women with hypoactive sexual desire disorder (HSDD).

Does sexual trauma contribute to dyspareunia?

October 16, 2018

A recent study examined similarities and differences between women who were exposed to sexual abuse and those with dyspareunia and is the first to actively compare these groups.

How prevalent are sexual problems among middle-aged Canadians?

September 11, 2018

A new study highlighted how common sexual dysfunction is among middle-aged persons and if the prevalence among Canadians is consistent with American and British reports. 

Patient-controlled expanding dilator for dyspareunia

August 09, 2018

Dilator therapy can be extremely successful in treating superficial dyspareunia, but compliance is often poor. A new type of vaginal dilator that gives women more control aims to address the issue.

What’s wrong with therapies for female sexual dysfunction?

August 09, 2018

A recent study quantified how much the treatment effect of pharmacologic modalities for female sexual dysfunction could be attributed to the placebo effect.

Pilot study finds oral SERM improves pain and sexual function

July 11, 2018

An oral selective estrogen receptor modulator approved for treatment of mild to moderate dyspareunia in menopausal women reduced signs and symptoms of atrophy in the vulva, vestibule, urethral meatus and vagina region, according to results of a prospective open-label pilot study